Drug intelligence / Profile preview

PF-00356231

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
01

Overview

PF-00356231 is an experimental small molecule inhibitor of matrix metalloproteinase 12 (MMP‑12). It is a non-peptidic, non-zinc chelating ligand that selectively inhibits MMP‑12 with an IC50 of approximately 1.4 μM. At higher concentrations, it may also inhibit other matrix metalloproteinases. The compound belongs to the phenylpyridine class and was developed as a potential therapeutic for conditions involving MMP‑12 activity, such as inflammatory or degenerative diseases[1][2][3][9]. Its chemical formula is C25H20N2O3S and its CAS number is 766536‑21‑4[1].

Other names
(3R)-3-Phenyl-3-[({4-[4-(4-pyridinyl)phenyl]-2-thienyl}carbonyl)amino]propanoic acid3-phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-yl]carbonyl}amino)propanoic acid
02

Targets

MMP12 (Macrophage Metalloelastase)

Beyond the preview

Go deeper on PF-00356231.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PF-00356231.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call